Forbes J M & Co. LLP Has $6.89 Million Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)

Forbes J M & Co. LLP grew its holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) by 461.4% in the 4th quarter, Holdings Channel reports. The fund owned 701,732 shares of the company’s stock after purchasing an additional 576,732 shares during the quarter. Forbes J M & Co. LLP’s holdings in Ginkgo Bioworks were worth $6,891,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of DNA. Erste Asset Management GmbH bought a new position in shares of Ginkgo Bioworks in the 3rd quarter valued at about $4,075,000. Jacobs Levy Equity Management Inc. bought a new position in Ginkgo Bioworks in the third quarter valued at approximately $2,282,000. PFG Investments LLC acquired a new position in shares of Ginkgo Bioworks during the 3rd quarter worth approximately $1,541,000. BNP Paribas Financial Markets bought a new position in shares of Ginkgo Bioworks in the third quarter valued at $1,287,000. Finally, PDT Partners LLC acquired a new position in Ginkgo Bioworks during the third quarter worth $1,199,000. Institutional investors and hedge funds own 78.63% of the company’s stock.

Ginkgo Bioworks Trading Up 4.2 %

Shares of DNA stock opened at $14.25 on Friday. Ginkgo Bioworks Holdings, Inc. has a 52-week low of $5.26 and a 52-week high of $64.40. The firm has a 50-day moving average price of $10.84.

Ginkgo Bioworks Company Profile

Ginkgo Bioworks Holdings, Inc, together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.